Announcements Trials
Browse Landscape

Phase

Phase 4 2Phase 3 2Phase 2 1Phase 1/2 1

Status

Completed 21Unknown 7Terminated 7Active not recruiting 7Recruiting 3Withdrawn 1Not yet recruiting 1

Sponsor Class

OTHER 4OTHER_GOV 1NIH 1INDUSTRY 1

Study Type

Interventional 6Observational 1

Sponsor

Cancer Type

Genitourinary 5Gastrointestinal 1

Conditions

Urinary Bladder Neoplasms 3Recurrence 1Rectal Neoplasms 1Prostatic Neoplasms 1Oligospermia 1Non-Muscle Invasive Bladder Neoplasms 1Fibrosis 1Colorectal Neoplasms 1Colonic Neoplasms 1

Interventions

Cisplatin 517Radiotherapy 378Cyclophosphamide 368Carboplatin 359Capecitabine 342Paclitaxel 337Oxaliplatin 336Gemcitabine 322Docetaxel 317Fluorouracil 290Drug Therapy 276Bevacizumab 248apatinib 247camrelizumab 219Etoposide 201Irinotecan 182Doxorubicin 181Leucovorin 163Dexamethasone 161pembrolizumab 153Neoadjuvant Therapy 146sintilimab 145anlotinib 140Blood Specimen Collection 140Pemetrexed 138Cytarabine 138toripalimab 133Surgical Procedures, Operative 131Radiosurgery 131S 1 (combination) 125

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

7 trials
RecentStart dateEnrollment
Unknown × BCG Vaccine × Clear all
NCT02948543 2023-06-18

BCG+MM

University of Sydney

Phase 3 Unknown
501 enrolled
Genitourinary

Urinary Bladder Neoplasms

NCT05701332 2023-01-27

Effect of Intravesical B.C.G and Gemcitabine on Semen Quality and Testicular Volume

Assiut University

Phase 4 Unknown
25 enrolled

Fibrosis, Oligospermia

NCT05332353 2022-04-18

Machine Learning-Based Prediction of BCG Response in High-Risk Non-Muscle Invasive Bladder Cancer Patients

Mansoura University

Unknown
100 enrolled
Genitourinary

Non-Muscle Invasive Bladder Neoplasms

NCT03664869 2021-04-01

FB10

Turku University Hospital

Phase 3 Unknown
300 enrolled
Genitourinary

Urinary Bladder Neoplasms, Recurrence

NCT03790384 2018-12-31

MITOBCG

Azienda Ospedaliera "Sant'Andrea"

Phase 4 Unknown
140 enrolled
Genitourinary

Urinary Bladder Neoplasms

NCT00007826 2013-09-20

Monoclonal Antibody Therapy and/or Vaccine Therapy in Treating Patients With Locally Advanced or Metastatic Colorectal Cancer

National Cancer Institute (NCI)

Phase 1/2 Unknown
Gastrointestinal

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

NCT00514072 2012-08-09

Vaccine Therapy in Treating Patients With Stage D0 Prostate Cancer

Kael-GemVax Co., Ltd.

Phase 2 Unknown
54 enrolled
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡